Claris Lifesciences Limited – Tender Offer

Stock quotes may be delayed unless otherwise stated
SUMMARY
POTENTIAL BUYBACK ANNOUNCEMENT
N/A

TENDER OFFER ANNOUNCEMENT
On January 7, 2014, Claris Lifesciences Limited (iq25071669) announced a tender offer to buyback 9.25 million shares at a buyback price of INR 250.00 per share. This represents a spread of 26.6% over the market price of INR 197.40 per share, as of the announcement date. The proposed buyback shares represents 14.49% of the total outstanding shares of 63.82 million. Given SEBI’s rule of preference to small shareholders who own less than INR 2 lakh worth of shares of the Company, approximately 1.39 million shares are reserved for small shareholders, which represents 15% of the proposed buyback.

Features – Tender Offer – Fixed Price
Share Price = INR 197.40
Buyback Price = INR 250.00
Spread = 26.6%
Buyback Size = 14.5% or 9.25 million shares

RECORD DATE ANNOUNCEMENT
The Company has fixed the record date of April 2, 2014 for the purpose of determining the entitlement and the names of equity shareholders who are eligible to participate in the buyback.

BUYBACK DATES ANNOUNCEMENT
The Company has announced the buyback open and close dates to participate in this tender offer. The buyback window for putting instructions opens on May 8, 2014 and closes on May 22, 2014.

RISK-REWARD ANALYSIS
ANALYSIS AS OF TENDER OFFER ANNOUNCEMENT DATE
Share Price = INR 197.40

Based on our research and analysis, the acceptance rate of this tender offer for small shareholders is expected to fall in the 90%-100% range. At the current price level, this represents an expected return between 24.0% and 26.6%. If the share price drops by 5%, the expected return would be between 23.5% and 26.6%. If the share price increases by 5%, the expected return would be between 24.5% and 26.6%. At 100% acceptance rate, the maximum return would be around 26.6%.
Based on the above risk-reward ratio analysis, Claris Lifesciences Limited tender offer appears to be an attractive low-risk arbitrage opportunity for small shareholders.

CONCLUSION = INVEST

ANALYSIS AS OF 3 DAYS PRIOR TO RECORD DATE
Share Price = INR 158.35

At the current price level and above mentioned acceptance rates, an expected return is between 52.1% and 57.9%. If the share price drops by 5%, the expected return would be between 51.6% and 57.9%. If the share price increases by 5%, the expected return would be between 52.6% and 57.9%. At 100% acceptance rate, the maximum return would be around 57.9%.
Based on the above risk-reward ratio analysis, Claris Lifesciences Limited tender offer continue to appear to be an attractive low-risk arbitrage opportunity for small shareholders.

CONCLUSION = STAY INVESTED

ANALYSIS AS OF BUYBACK OPEN DATE
Share Price = INR 158.75

At the current price level and above mentioned acceptance rates, an expected return is between 51.7% and 57.5%. If the share price drops by 5%, the expected return would be between 51.2% and 57.5%. If the share price increases by 5%, the expected return would be between 52.2% and 57.5%.
Based on the above risk-reward ratio analysis, Claris Lifesciences Limited tender offer continue to appear to be an attractive low-risk arbitrage opportunity for small shareholders.

CONCLUSION = PARTICIPATE

POST-BUYBACK ANNOUNCEMENT & RESULT
On May 22, 2014, Claris Lifesciences Limited (iq25071669) announced the final results of the buyback. A total of 2.36 million shares were tendered by small shareholders, out of which 1.39 million shares were accepted. Therefore, the actual acceptance rate for small shareholders turned out to be approximately 59%. The share price decreased by 14.3% since the tender offer announcement, which includes 17.6% decrease between the tender offer announcement and record date, and 3.3% increase between the record date and closing date.

Share Price = INR 169.15

Given we decided to INVEST at the time of tender offer announcement, decided to STAY INVESTED at the time of record date and decided to PARTICIPATE at the time of buyback open date, the net realized return was 9.7% over a span of 135 days, which is equivalent to an annualized return of 28.5%.

RESULT = PROFIT
RETURN = 9.7%
DURATION = 135 days
ANNUALIZED IRR = 28.5%

REFERENCE LINKS/FILINGS

Tender Offer Announcement
Record Date Announcement
Buyback Dates Announcement
Post Buyback Announcement

DISCLAIMER & DISCLOSURE
The above post/article should not be considered as a stock recommendation or trading/investing advice in any way. The stock analysis is based on the information publicly available to author, however readers should check the original source of information. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. At the time of writing this post author may have a financial interest or ownership in the discussed stock or initiate a position anytime in future.